| Line item | 2025-12-31 FY | 2024-12-31 FY | 2023-12-31 FY | 2022-12-31 FY | 2021-12-31 FY |
|---|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | – | – | – |
| Cost of Revenue | – | – | – | – | – |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | $56.38M | $19.49M | $8.23M | $11.05M | $32.73M |
| R&D | $32.67M | $12.71M | $3.23M | $5.38M | $25.15M |
| SG&A | $23.71M | $6.79M | $5.01M | $5.68M | $7.58M |
| Operating Income | -$56.38M | -$19.49M | $8.23M | -$11.05M | $32.73M |
| Interest Expense | $0.00 | $23.00K | $23.97K | $4.44K | $949.00 |
| Tax Expense | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Net Income | -$52.60M | -$17.60M | $7.71M | -$11.05M | -$32.47M |
| EPS (basic) | -1.3400 | -1.1500 | -31.0400 | – | – |
| EPS (diluted) | -1.3400 | -1.1500 | -31.0400 | – | – |
| Shares (diluted) | $39.22M | $15.27M | $248.45K | – | – |